You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Icosapent ethyl

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule

Recruiting
  • Cardiovascular Diseases
  • +3 more
  • Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
  • North York, Ontario, Canada
  • +3 more
Nov 7, 2022

Covid19, Atherosclerosis, Cardiovascular Diseases Trial in Oakland (Icosapent ethyl)

Active, not recruiting
  • Covid19
  • +3 more
  • Icosapent ethyl
  • Oakland, California
    Kaiser Permanente Northern California
Jan 7, 2022

COVID-19, Inflammatory Response Trial in Toronto (Icosapent ethyl)

Completed
  • COVID-19
  • Inflammatory Response
  • Icosapent ethyl
  • Toronto, Ontario, Canada
    North York Diagnostic and Cardiology Clinic
Dec 21, 2021

Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)

Withdrawn
  • Bipolar Disorder
  • Ethyl Eicosapentaenoic Acid
  • New York, New York
    New York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022

Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertriglyceridemia
  • Metformin Eicosapentaenoate
  • Metformin HCl and Vascepa
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Apr 25, 2022

Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )

Active, not recruiting
  • Alzheimer's Disease
  • icosapent ethyl (IPE)
  • gel cap placebo
  • Madison, Wisconsin
    William S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021

Type 2 Diabetes, Coronary Artery Disease Trial in Boston (Icosapent ethyl)

Terminated
Has Results
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Icosapent ethyl
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 22, 2022

Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))

Withdrawn
  • Colon Cancer
  • AMR101 (VASCEPA, icosapent ethyl)
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 10, 2021

Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

Completed
Has Results
  • Lipid Disorder
  • +2 more
  • Icosapent Ethyl 1000 MG [Vascepa]
  • Philadelphia, Pennsylvania
    Perelman School of Medicine at the University of Pennsylvania
Oct 15, 2021

COVID19 Trial in Rosario (Icosapent ethyl (IPE), Placebo)

Completed
  • COVID19
  • Icosapent ethyl (IPE)
  • Placebo
  • Rosario, Santa Fe, Argentina
    Instituto de Investigaciones Clínicas - Rosario
Sep 10, 2021

Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)

Recruiting
  • Liver Metastasis
  • Colon Cancer
  • Icosapent Ethyl
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +12 more
Nov 7, 2022

Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver

Recruiting
  • Colon Cancer Liver Metastasis
  • Icosapent Ethyl Oral Capsule
  • Placebo
  • Leeds, United Kingdom
  • +1 more
Sep 27, 2021

Hypertriglyceridemia Trial in United States (Omega 3 pentaenoic acid, icosapent ethyl)

Completed
Has Results
  • Hypertriglyceridemia
  • Omega 3 pentaenoic acid
  • icosapent ethyl
  • Jacksonville, Florida
  • +7 more
Mar 3, 2022

People of South Asian Descent With Atherosclerotic

Active, not recruiting
  • Cardiovascular Diseases
  • +3 more
    • Ajax, Ontario, Canada
    • +4 more
    Apr 25, 2022

    Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)

    Completed
    Has Results
    • Cardiovascular Diseases
    • Birmingham, Alabama
    • +409 more
    Mar 21, 2022

    Diabetes Type 2, Hypertriglyceridemia, Diabetes Trial in Ioannina (EPAVasc, Corn Oil)

    Not yet recruiting
    • Diabetes Type 2
    • +2 more
    • EPAVasc
    • Corn Oil
    • Ioannina, Epirus, Greece
      Atherothrombosis Research Centre / Laboratory of Biochemistry, U
    Nov 13, 2023

    Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)

    Completed
    • Colorectal Adenoma
    • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 18, 2022

    Novel Cardiovascular Biomarkers in Patients With Kidney Disease

    Not yet recruiting
    • Haemodialysis Complication
    • Major Adverse Cardiac Events
    • Cardiac Biomarkers
    • +2 more
    • (no location specified)
    Sep 14, 2023

    Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)

    Recruiting
    • Healthy
    • Rodatristat Ethyl
    • +3 more
    • Overland Park, Kansas
      Altasciences Clinical Kansas, Inc.
    Jul 5, 2023

    Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

    Recruiting
    • Locally Advanced Neuroendocrine Neoplasm
    • Metastatic Neuroendocrine Neoplasm
    • Placebo Administration
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2023

    Healthy Trial in Austin (Rodatristat Ethyl, Placebo)

    Completed
    • Healthy
    • Rodatristat Ethyl
    • Placebo
    • Austin, Texas
      PPD Development
    Jan 25, 2023

    Irreversible Pulpitis Trial in Karachi (Ethyl chloride, Honey)

    Completed
    • Irreversible Pulpitis
    • Ethyl chloride
    • Honey
    • Karachi, Sindh, Pakistan
      Hira Danish
    Oct 29, 2022

    Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)

    Completed
    Has Results
    • Coronary Artery Disease (CAD)
    • Los Angeles, California
    • +32 more
    Apr 7, 2022

    Lumbar Spine Stenosis Specimens for Identification of

    Not yet recruiting
    • Lumbar Spinal Stenosis
    • +5 more
    • Tc99-PYP or Tc99-HDMP Scan
    • Beverly Hills, California
    • +5 more
    Sep 12, 2023

    Pulmonary Arterial Hypertension Trial in Worldwide (rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • rodatristat ethyl 300 mg tablet BID
    • +2 more
    • Phoenix, Arizona
    • +59 more
    Jul 11, 2022